• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠溶胶囊填充冷冻干燥壳聚糖/聚(γ-谷氨酸)纳米粒用于口服胰岛素传递。

Enteric-coated capsules filled with freeze-dried chitosan/poly(gamma-glutamic acid) nanoparticles for oral insulin delivery.

机构信息

Department of Chemical Engineering, National Tsing Hua University, Hsinchu, Taiwan, ROC.

出版信息

Biomaterials. 2010 Apr;31(12):3384-94. doi: 10.1016/j.biomaterials.2010.01.042. Epub 2010 Feb 10.

DOI:10.1016/j.biomaterials.2010.01.042
PMID:20149435
Abstract

A pH-sensitive nanoparticle (NP) system composed of chitosan and poly(gamma-glutamic acid) was prepared for the oral delivery of insulin. The biodistribution study in a rat model showed that some of the orally administered NPs were retained in the stomach for a long duration, which might lead to the disintegration of NPs and degradation of insulin. To overcome these problems, we freeze-dried NPs and filled them in an enteric-coated capsule. The small angle X-ray scattering (SAXS) profiles indicated that the freeze-drying process did not significantly disrupt the internal structure of NPs; additionally, their pH-sensitivity was preserved and the insulin release was pH-dependent. The results obtained in the native PAGE analysis indicated that the released insulin molecules were neither fragmented nor aggregated. Upon oral administration, the enteric-coated capsule remained intact in the acidic environment of the stomach, but dissolved rapidly in the proximal segment of the small intestine. Consequently, all the NPs loaded in the capsule were brought into the small intestine, thus enhancing the intestinal absorption of insulin and providing a prolonged reduction in blood glucose levels. The relative bioavailability of insulin was found to be approximately 20%. These results suggest that the formulation developed in the study might be employed as a potential approach for the oral delivery of insulin.

摘要

一种由壳聚糖和聚(γ-谷氨酸)组成的 pH 敏感纳米颗粒(NP)系统被制备用于胰岛素的口服递送。在大鼠模型中的体内分布研究表明,一些口服给予的 NPs 在胃中长时间保留,这可能导致 NPs 的崩解和胰岛素的降解。为了克服这些问题,我们将 NPs 冷冻干燥并填充在肠溶胶囊中。小角 X 射线散射(SAXS)谱表明,冷冻干燥过程并未显著破坏 NPs 的内部结构;此外,它们的 pH 敏感性得以保留,并且胰岛素的释放是 pH 依赖性的。天然 PAGE 分析的结果表明,释放的胰岛素分子既没有碎片化也没有聚集。口服给予时,肠溶胶囊在胃的酸性环境中保持完整,但在小肠的近端迅速溶解。因此,胶囊中装载的所有 NPs 都被带入小肠,从而增强了胰岛素的肠道吸收,并提供了血糖水平的长时间降低。胰岛素的相对生物利用度约为 20%。这些结果表明,研究中开发的制剂可能被用作胰岛素口服递送的潜在方法。

相似文献

1
Enteric-coated capsules filled with freeze-dried chitosan/poly(gamma-glutamic acid) nanoparticles for oral insulin delivery.肠溶胶囊填充冷冻干燥壳聚糖/聚(γ-谷氨酸)纳米粒用于口服胰岛素传递。
Biomaterials. 2010 Apr;31(12):3384-94. doi: 10.1016/j.biomaterials.2010.01.042. Epub 2010 Feb 10.
2
Protease inhibition and absorption enhancement by functional nanoparticles for effective oral insulin delivery.功能纳米粒通过抑制蛋白酶和增强吸收作用实现有效的口服胰岛素传递。
Biomaterials. 2012 Mar;33(9):2801-11. doi: 10.1016/j.biomaterials.2011.12.038. Epub 2012 Jan 11.
3
HP55-coated capsule containing PLGA/RS nanoparticles for oral delivery of insulin.载有 PLGA/RS 纳米粒的 HP55 包衣胶囊,用于胰岛素的口服递送。
Int J Pharm. 2012 Apr 4;425(1-2):1-8. doi: 10.1016/j.ijpharm.2011.12.055. Epub 2012 Jan 12.
4
pH-responsive nanoparticles shelled with chitosan for oral delivery of insulin: from mechanism to therapeutic applications.壳聚糖包裹的 pH 响应性纳米粒用于胰岛素的口服递送:从机制到治疗应用。
Acc Chem Res. 2012 Apr 17;45(4):619-29. doi: 10.1021/ar200234q. Epub 2012 Jan 11.
5
Preparation and characterization of nanoparticles shelled with chitosan for oral insulin delivery.用于口服胰岛素递送的壳聚糖包被纳米颗粒的制备与表征
Biomacromolecules. 2007 Jan;8(1):146-52. doi: 10.1021/bm0607776.
6
Noninvasive imaging oral absorption of insulin delivered by nanoparticles and its stimulated glucose utilization in controlling postprandial hyperglycemia during OGTT in diabetic rats.经纳米粒递药后胰岛素经口腔吸收的无创性影像学研究及其对糖尿病大鼠 OGTT 后餐后高血糖的葡萄糖刺激利用作用。
J Control Release. 2013 Dec 10;172(2):513-22. doi: 10.1016/j.jconrel.2013.05.006. Epub 2013 May 21.
7
Freeze dried chitosan/ poly-(glutamic acid) microparticles for intestinal delivery of lansoprazole.冷冻干燥壳聚糖/聚(谷氨酸)微球用于兰索拉唑的肠道递药。
Curr Drug Deliv. 2012 Jan;9(1):95-104. doi: 10.2174/156720112798376041.
8
Design, characterisation, and bioefficiency of insulin-chitosan nanoparticles after stabilisation by freeze-drying or cross-linking.冻干或交联稳定后胰岛素-壳聚糖纳米粒的设计、表征及生物效率
Int J Pharm. 2015 Aug 1;491(1-2):402-8. doi: 10.1016/j.ijpharm.2015.05.065. Epub 2015 Jun 3.
9
The glucose-lowering potential of exendin-4 orally delivered via a pH-sensitive nanoparticle vehicle and effects on subsequent insulin secretion in vivo.Exendin-4 通过 pH 敏感型纳米载体经口服给药的降血糖作用及其对体内胰岛素分泌的后续影响。
Biomaterials. 2011 Apr;32(10):2673-82. doi: 10.1016/j.biomaterials.2010.12.044. Epub 2011 Jan 21.
10
In vivo evaluation of safety and efficacy of self-assembled nanoparticles for oral insulin delivery.用于口服胰岛素递送的自组装纳米颗粒的体内安全性和有效性评估。
Biomaterials. 2009 Apr;30(12):2329-39. doi: 10.1016/j.biomaterials.2008.12.066. Epub 2009 Jan 26.

引用本文的文献

1
Current Advancements on Oral Protein and Peptide Drug Delivery Approaches to Bioavailability: Extensive Review on Patents.口服蛋白和肽类药物传递方法生物利用度的最新进展:专利广泛综述。
Recent Adv Drug Deliv Formul. 2024;18(4):227-246. doi: 10.2174/0126673878299775240719061653.
2
pH and HO dual-sensitive nanoparticles enable enhanced and safe glucose-responsive oral insulin delivery for diabetes mellitus treatment.pH 和 HO 双重敏感纳米粒增强并安全实现葡萄糖响应性口服胰岛素递药用于糖尿病治疗
Theranostics. 2024 Sep 3;14(14):5596-5607. doi: 10.7150/thno.98177. eCollection 2024.
3
Design of Auto-Adaptive Drug Delivery System for Effective Delivery of Peptide Drugs to Overcoming Mucus and Epithelial Barriers.
用于克服黏液和上皮屏障的有效递肽药物的自适应性药物输送系统的设计。
AAPS J. 2024 Sep 12;26(5):102. doi: 10.1208/s12248-024-00971-1.
4
Recent advances in oral insulin delivery technologies.口服胰岛素递药技术的最新进展。
J Control Release. 2024 Feb;366:221-230. doi: 10.1016/j.jconrel.2023.12.045. Epub 2024 Jan 4.
5
Preparation and Characterization of a Novel Multiparticulate Dosage Form Carrying Budesonide-Loaded Chitosan Nanoparticles to Enhance the Efficiency of Pellets in the Colon.一种新型多颗粒剂型的制备与表征,该剂型载有布地奈德壳聚糖纳米颗粒以提高结肠中微丸的效率。
Pharmaceutics. 2022 Dec 26;15(1):69. doi: 10.3390/pharmaceutics15010069.
6
Commercially Available Enteric Empty Hard Capsules, Production Technology and Application.市售肠溶空心硬胶囊、生产工艺及应用
Pharmaceuticals (Basel). 2022 Nov 13;15(11):1398. doi: 10.3390/ph15111398.
7
Enteric Polymer-Coated Porous Silicon Nanoparticles for Site-Specific Oral Delivery of IgA Antibody.用于 IgA 抗体靶向口服递释的肠溶性聚合物包覆多孔硅纳米粒子。
ACS Biomater Sci Eng. 2022 Oct 10;8(10):4140-4152. doi: 10.1021/acsbiomaterials.0c01313. Epub 2020 Nov 20.
8
Nanocarriers as a Delivery Platform for Anticancer Treatment: Biological Limits and Perspectives in B-Cell Malignancies.作为抗癌治疗递送平台的纳米载体:B细胞恶性肿瘤的生物学局限与前景
Pharmaceutics. 2022 Sep 17;14(9):1965. doi: 10.3390/pharmaceutics14091965.
9
Development and Comparison of Various Coated Hard Capsules Suitable for Enteric Administration to Small Patient Cohorts.适用于小患者群体肠溶给药的各种包衣硬胶囊的开发与比较
Pharmaceutics. 2022 Jul 29;14(8):1577. doi: 10.3390/pharmaceutics14081577.
10
The intestinal absorption mechanism of chicoric acid and its bioavailability improvement with chitosan.菊苣酸的肠道吸收机制及其壳聚糖对其生物利用度的改善
Heliyon. 2022 Jul 14;8(7):e09955. doi: 10.1016/j.heliyon.2022.e09955. eCollection 2022 Jul.